PMC:7073332 / 430-1343
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
47 | 358-363 | Species | denotes | human | Tax:9606 |
48 | 460-469 | Species | denotes | 2019-nCoV | Tax:2697049 |
49 | 470-480 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
50 | 534-542 | Species | denotes | SARS-CoV | Tax:694009 |
51 | 608-617 | Species | denotes | 2019-nCoV | Tax:2697049 |
52 | 618-628 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
53 | 746-754 | Species | denotes | SARS-CoV | Tax:694009 |
54 | 839-844 | Species | denotes | human | Tax:9606 |
59 | 312-316 | Species | denotes | HCoV | Tax:694448 |
60 | 429-433 | Species | denotes | HCoV | Tax:694448 |
61 | 809-813 | Species | denotes | HCoV | Tax:694448 |
62 | 890-894 | Species | denotes | HCoV | Tax:694448 |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T1 | 364-371 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T2 | 372-379 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T3 | 440-447 | Body_part | denotes | genomes | http://purl.org/sig/ont/fma/fma84116 |
T4 | 500-510 | Body_part | denotes | nucleotide | http://purl.org/sig/ont/fma/fma82740 |
T5 | 596-604 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T6 | 470-478 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T7 | 534-542 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T8 | 618-626 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T9 | 746-754 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T2 | 218-219 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T3 | 358-371 | http://purl.obolibrary.org/obo/PR_000029067 | denotes | human protein |
T4 | 839-844 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T3 | 0-4 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T4 | 38-43 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
T5 | 108-112 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T6 | 166-180 | Chemical | denotes | antiviral drug | http://purl.obolibrary.org/obo/CHEBI_36044 |
T7 | 166-175 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
T8 | 176-180 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T9 | 255-263 | Chemical | denotes | medicine | http://purl.obolibrary.org/obo/CHEBI_23888 |
T10 | 338-342 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T11 | 364-371 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T12 | 372-379 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T13 | 500-510 | Chemical | denotes | nucleotide | http://purl.obolibrary.org/obo/CHEBI_36976 |
T14 | 596-604 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
T15 | 792-796 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T16 | 908-913 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T6 | 124-400 | Sentence | denotes | In this study, we present an integrative, antiviral drug repurposing methodology implementing a systems pharmacology-based network medicine platform, quantifying the interplay between the HCoV–host interactome and drug targets in the human protein–protein interaction network. |
T7 | 401-551 | Sentence | denotes | Phylogenetic analyses of 15 HCoV whole genomes reveal that 2019-nCoV/SARS-CoV-2 shares the highest nucleotide sequence identity with SARS-CoV (79.7%). |
T8 | 552-755 | Sentence | denotes | Specifically, the envelope and nucleocapsid proteins of 2019-nCoV/SARS-CoV-2 are two evolutionarily conserved regions, having the sequence identities of 96% and 89.6%, respectively, compared to SARS-CoV. |